Zoetis Acquires VitalRADS to Boost Veterinary Diagnostics

Zoetis Agrees to Acquire VitalRADS, Expanding Veterinary Teleradiology Capabilities 

PARSIPPANY, New Jersey — July 17, 2026 — Zoetis Inc., a global leader in animal health medicines and vaccines, has announced a definitive agreement to acquire VitalRADS, a veterinary teleradiology services platform, in a strategic move that underscores the accelerating convergence of digital technology and diagnostic innovation within the global animal health sector. 

Main Development 

The transaction, expected to close in the third quarter of 2026, will integrate VitalRADS's remote radiology interpretation services into Zoetis's existing diagnostic portfolio. VitalRADS enables veterinary practices to access specialist-level radiological analysis without the requirement for on-site radiologists — a capability increasingly in demand as companion animal care standards continue to rise across North America and globally. 

The acquisition reflects a broader industry shift toward digitization of veterinary services, as pet ownership rates climb and animal owners increasingly seek specialist-grade diagnostic support. The deal positions Zoetis to deepen its footprint in the companion animal diagnostics segment, which has emerged as one of the fastest-growing categories within the animal health industry. 

The announcement coincides with a period of active earnings reporting across the sector. Boehringer Ingelheim reported first-half 2026 net sales of €2.6 billion ($2.98 billion) for its Animal Health Business, representing a currency-adjusted 0.4% increase year-over-year. Separately, Eco Animal Health Group reported full fiscal year 2026 group sales of £87.5 million ($117.88 million), a 10% increase over the prior fiscal year. 

The global animal health market is projected to reach USD 80.12 billion by 2030, registering a compound annual growth rate (CAGR) of 7.0% from 2024 to 2030, according to Next Move Strategy Consulting. 

Key Highlights: 

• Zoetis announced a definitive agreement to acquire VitalRADS, a veterinary teleradiology services platform, with the transaction expected to close in Q3 2026. 

• The acquisition is designed to accelerate Zoetis's diagnostic capabilities by integrating remote radiology interpretation services into its veterinary portfolio. 

• Boehringer Ingelheim reported H1 2026 Animal Health net sales of €2.6 billion ($2.98 billion), a currency-adjusted 0.4% increase year-over-year. 

• The global animal health market is valued at USD 50.10 billion (2023) and is forecast to reach USD 80.12 billion by 2030 at a CAGR of 7.0%, per Next Move Strategy Consulting. 

Analyst Insight: 

According to analysts at Next Move Strategy Consulting, the animal health market is being propelled by growing demand for protein-based food, heightened awareness of zoonotic and food-borne diseases, and increasing government initiatives to strengthen animal healthcare infrastructure globally. NMSC analysts note that the integration of teleradiology and digital diagnostic platforms into major animal health portfolios reflects the sector's accelerating shift toward technology-driven, preventive care models. North America is expected to retain the dominant regional market share through 2030, supported by high companion animal ownership rates, elevated consumer disposable incomes, and rapid advancements in veterinary pharmaceutical research and development. 

Industry Outlook: 

The Zoetis-VitalRADS acquisition signals a continued consolidation trend within the global animal health sector, as leading companies seek to broaden their diagnostic and digital service offerings. With the market projected to grow at a 7.0% CAGR through 2030, industry participants are expected to intensify investments in telehealth infrastructure, AI-assisted diagnostics, and preventive care platforms to meet the evolving demands of veterinary professionals and animal owners worldwide. 

Source: Brakke Consulting 

For More Information – Download FREE Sample on Animal Health Market Report

Prepared By: Sanyukta Deb